HIV-1-infection Clinical Trials in New York, New York

4 studies are recruiting for hiv-1-infection in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

   The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virologically suppressed peopl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   NYU Langone Health Vaccine Center, New York, New York

   Locations

   55 in total

   Run by

   Gilead Sciences

   See if you can join NCT07645287 on ClinicalTrials.gov

2. A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

   This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will also test the anti-viral activity of BNT351 in people living with HIV (PLWH) with detectable virus levels. The main goals of this study are: …

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Columbia University, New York, New York

   Locations

   6 in total

   Run by

   BioNTech SE

   See if you can join NCT07392372 on ClinicalTrials.gov

3. Ending the Epidemic Interventions in the Dental Setting - UH3

   The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York

   Locations

   3 in total

   Run by

   Columbia University

   See if you can join NCT06890988 on ClinicalTrials.gov

4. Observational PIC Destination Cohort

   This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is also being used to try to understand how people control HIV without ART after receiving an interventio…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Weill Cornell Upton CRS (7803), New York, New York

   Locations

   4 in total

   Run by

   Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

   See if you can join NCT05985642 on ClinicalTrials.gov